930 Search Results Found For : "Low-priced medicines https://simplemedrx.top""



Project: Empowering Evidence-Driven Advocacy

Infographic. Intrauterine Device (IUD)

The copper IUD is a T-shaped plastic device wrapped in copper wire. The hormonal IUD is a T-shaped plastic device that contains 52 milligrams of levonorgestrel (progestin hormone). Both are long-acting reversible contraceptive methods. The copper IUD is effective for 10 years and the hormonal IUD is effective for three to five years. This method must be inserted and removed by a trained provider and does not contain estrogen.

View Details Array ( [ID] => 11382 [id] => 11382 [title] => PHL_Fact_Sheets_IUD [filename] => PHL_Fact_Sheets_IUD.pdf [filesize] => 584065 [url] => https://www.prb.org/wp-content/uploads/2021/01/PHL_Fact_Sheets_IUD.pdf [link] => https://www.prb.org/resources/combined-oral-contraceptive/phl_fact_sheets_iud-2/ [alt] => [author] => 15 [description] => [caption] => [name] => phl_fact_sheets_iud-2 [status] => inherit [uploaded_to] => 11375 [date] => 2021-01-09 05:08:55 [modified] => 2021-01-09 05:08:55 [menu_order] => 0 [mime_type] => application/pdf [type] => application [subtype] => pdf [icon] => https://www.prb.org/wp-includes/images/media/document.png ) Download (0.6 MB)

Project: Empowering Evidence-Driven Advocacy

Infographic. Injectable Contraceptive

The injectable contraceptive is a progestin-only dose of depot medroxyprogesterone acetate (DMPA), a progestin that mimics the natural progesterone hormone. Two DMPA formulas exist: One is administered into the muscle and one is administered into the tissue layer under the skin. The short-term reversible contraceptive method is effective for about three months. The injectable should be administered by a trained provider every three months to maintain protection from unintended pregnancies. The progestin-only injectable does not contain estrogen.

View Details Array ( [ID] => 11383 [id] => 11383 [title] => PHL_Fact_Sheets_Injectables [filename] => PHL_Fact_Sheets_Injectables.pdf [filesize] => 583267 [url] => https://www.prb.org/wp-content/uploads/2021/01/PHL_Fact_Sheets_Injectables.pdf [link] => https://www.prb.org/resources/combined-oral-contraceptive/phl_fact_sheets_injectables-2/ [alt] => [author] => 15 [description] => [caption] => [name] => phl_fact_sheets_injectables-2 [status] => inherit [uploaded_to] => 11375 [date] => 2021-01-09 05:08:58 [modified] => 2021-01-09 05:08:58 [menu_order] => 0 [mime_type] => application/pdf [type] => application [subtype] => pdf [icon] => https://www.prb.org/wp-includes/images/media/document.png ) Download (0.6 MB)

Project: Empowering Evidence-Driven Advocacy

Infographic. Contraceptive Implant

The etonorgestrel (ENG)-releasing subdermal implant is a small plastic rod that is four centimeters in length and contains 68 milligrams of the progestin ENG. The implant is a long-acting reversible contraceptive method that is effective for three years. It must be inserted and removed by a trained provider and does not contain estrogen.

View Details Array ( [ID] => 11384 [id] => 11384 [title] => PHL_Fact_Sheets_Implants [filename] => PHL_Fact_Sheets_Implants.pdf [filesize] => 574052 [url] => https://www.prb.org/wp-content/uploads/2021/01/PHL_Fact_Sheets_Implants.pdf [link] => https://www.prb.org/resources/combined-oral-contraceptive/phl_fact_sheets_implants-2/ [alt] => [author] => 15 [description] => The etonorgestrel (ENG)-releasing subdermal implant is a small plastic rod that is four centimeters in length and contains 68 milligrams of the progestin ENG. The implant is a long-acting reversible contraceptive method that is effective for three years. It must be inserted and removed by a trained provider and does not contain estrogen. [caption] => [name] => phl_fact_sheets_implants-2 [status] => inherit [uploaded_to] => 11375 [date] => 2021-01-09 05:09:01 [modified] => 2021-01-09 05:18:43 [menu_order] => 0 [mime_type] => application/pdf [type] => application [subtype] => pdf [icon] => https://www.prb.org/wp-includes/images/media/document.png ) Download (0.6 MB)

Malnutrition: Nigeria’s Silent Crisis

Each year about 1 million Nigerian children die before their fifth birthday. Malnutrition contributes to nearly half of these deaths. The multimedia presentation, Malnutrition: Nigeria’s Silent Crisis, presents the reasons why proper nutrition for women and children is so important, especially in the first 1,000 day period—from the start of a woman’s pregnancy until her child’s second birthday

View Details

Path to Prosperity: Empower, Educate, and Employ Youth to Realize the Demographic Dividend

Investments in young people are crucial to achieving a demographic dividend. The demographic dividend provides a framework for promoting investments in youth as fertility declines and population age structure changes. Sustained investments in voluntary family planning, health, education, and job growth can help to guide a country towards a demographic dividend.

View Details

Project: Demography and Economics of Aging and Alzheimer’s Disease

Key Factors Underlying Racial Disparities in Health Between Black and White Older Americans

Socioeconomic inequality and racism-related stress are at the root of Black-white health disparities, requiring policies and interventions targeting both economic inequality and exposure to high levels of stress.

View Details

Project: Empowering Evidence-Driven Advocacy

Infographic. Combined Oral Contraceptive

Combined oral contraception is a daily pill that contains low doses of estrogen and progestin to prevent pregnancy. The method is a short-term reversible contraceptive option. Effectiveness depends on user’s adherence.

View Details Array ( [ID] => 11385 [id] => 11385 [title] => PHL_Fact_Sheets_Combined_Oral_Contraceptives [filename] => PHL_Fact_Sheets_Combined_Oral_Contraceptives.pdf [filesize] => 578194 [url] => https://www.prb.org/wp-content/uploads/2021/01/PHL_Fact_Sheets_Combined_Oral_Contraceptives.pdf [link] => https://www.prb.org/resources/combined-oral-contraceptive/phl_fact_sheets_combined_oral_contraceptives-2/ [alt] => [author] => 15 [description] => [caption] => [name] => phl_fact_sheets_combined_oral_contraceptives-2 [status] => inherit [uploaded_to] => 11375 [date] => 2021-01-09 05:09:04 [modified] => 2021-01-09 05:09:04 [menu_order] => 0 [mime_type] => application/pdf [type] => application [subtype] => pdf [icon] => https://www.prb.org/wp-includes/images/media/document.png ) Download (0.6 MB)

Project: Empowering Evidence-Driven Advocacy

Engaging Ethiopian Youth as Equal Partners in Their Sexual and Reproductive Health and Providing Them With Quality Information

In 2018, Population Reference Bureau (PRB) and the International Youth Alliance for Family Planning (IYAFP) conducted interviews and focus groups in three Ethiopian regions to assess implementation of youth-friendly contraceptive services.

View Details

Project: KIDS COUNT Technical Assistance and Training

Data 101 Tutorials on the American Community Survey

In this video tutorial series, PRB introduces data users to the American Community Survey and provides key information about how to access and use ACS data.

View Details